Artificial Intelligence-AI-and The Journal of Pediatric Pharmacology and Therapeutics
- PMID: 37795286
- PMCID: PMC10547040
- DOI: 10.5863/1551-6776-28.4.284
Artificial Intelligence-AI-and The Journal of Pediatric Pharmacology and Therapeutics
Conflict of interest statement
Disclosures. The author is the Editor-in-Chief of The Journal of Pediatric Pharmacology and Therapeutics. The author declares no conflicts or financial interest in any product or service mentioned in this editorial, including grants, equipment, employment, gifts, and honoraria.
References
-
- Schinkel M, Paranjape K, Nanayakkara P. Written by humans or artificial intelligence: that is the question. Ann Intern Med . 2023;176(4):572–573. - PubMed
-
- US Food and Drug Administration. Using artificial intelligence & machine learning in the development of drug & biological products. May 5, 2023. Accessed May 17, 2023, FDA.Gov.
-
- Lima C. How OpenAI CEO Sam Altman won over Washington—for now. Washington Post . May 17, 2023.
-
- McCabe D. Microsoft calls for AI rules to minimize the technology’s risks. New York Times . 2023. May 25.
-
- Metz C, Issac M. In battle over AI, Meta decides to give away its crown jewels. New York Times . May 18, 2023.
LinkOut - more resources
Full Text Sources